These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 22380407

  • 21. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
    Ogino S, Hazra A, Tranah GJ, Kirkner GJ, Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Meyerhardt JA, Hunter DJ, Fuchs CS.
    Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
    [Abstract] [Full Text] [Related]

  • 22. Long-term survival with glioblastoma multiforme.
    Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G, Weller M, Schackert G, German Glioma Network.
    Brain; 2007 Oct; 130(Pt 10):2596-606. PubMed ID: 17785346
    [Abstract] [Full Text] [Related]

  • 23. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
    Sharma G, Mirza S, Parshad R, Srivastava A, Gupta SD, Pandya P, Ralhan R.
    Life Sci; 2010 Jul 17; 87(3-4):83-91. PubMed ID: 20470789
    [Abstract] [Full Text] [Related]

  • 24. Pathodiagnostic parameters and evaluation of O⁶- methyl guanine methyl transferase gene promoter methylation in meningiomas.
    Jabini R, Moradi A, Afsharnezhad S, Ayatollahi H, Behravan J, Raziee HR, Mosaffa F.
    Gene; 2014 Apr 01; 538(2):348-53. PubMed ID: 24398011
    [Abstract] [Full Text] [Related]

  • 25. Methylation of O6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patients.
    Fumagalli C, Pruneri G, Possanzini P, Manzotti M, Barile M, Feroce I, Colleoni M, Bonanni B, Maisonneuve P, Radice P, Viale G, Barberis M.
    Breast Cancer Res Treat; 2012 Jul 01; 134(1):131-7. PubMed ID: 22228432
    [Abstract] [Full Text] [Related]

  • 26. Quantitative digital assessment of MGMT immunohistochemical expression in glioblastoma tissue.
    Araki Y, Mizoguchi M, Yoshimoto K, Shono T, Amano T, Nakamizo A, Suzuki SO, Iwaki T, Sasaki T.
    Brain Tumor Pathol; 2011 Feb 01; 28(1):25-31. PubMed ID: 21249460
    [Abstract] [Full Text] [Related]

  • 27. Pathological findings and prognostic factors in recurrent glioblastomas.
    Okita Y, Narita Y, Miyakita Y, Ohno M, Fukushima S, Kayama T, Shibui S.
    Brain Tumor Pathol; 2012 Oct 01; 29(4):192-200. PubMed ID: 22331317
    [Abstract] [Full Text] [Related]

  • 28. Chromosome 1p/19q status combined with expression of p53 protein improves the diagnostic and prognostic evaluation of oligodendrogliomas.
    Xiong J, Liu Y, Wang Y, Ke RH, Mao Y, Ye ZR.
    Chin Med J (Engl); 2010 Dec 01; 123(24):3566-73. PubMed ID: 22166632
    [Abstract] [Full Text] [Related]

  • 29. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
    Galanis E, Buckner JC, Dinapoli RP, Scheithauer BW, Jenkins RB, Wang CH, O'Fallon JR, Farr G.
    J Neurosurg; 1998 Sep 01; 89(3):425-30. PubMed ID: 9724117
    [Abstract] [Full Text] [Related]

  • 30. Craniotomy for recurrent glioblastoma: Is it justified? A comparative cohort study with outcomes over 10 years.
    Mukherjee S, Wood J, Liaquat I, Stapleton SR, Martin AJ.
    Clin Neurol Neurosurg; 2020 Jan 01; 188():105568. PubMed ID: 31739155
    [Abstract] [Full Text] [Related]

  • 31. Demographic, radiographic, molecular and clinical characteristics of primary gliosarcoma and differences to glioblastoma.
    Pierscianek D, Ahmadipour Y, Michel A, Rauschenbach L, Darkwah Oppong M, Deuschl C, Kebir S, Wrede KH, Glas M, Stuschke M, Sure U, Jabbarli R.
    Clin Neurol Neurosurg; 2021 Jan 01; 200():106348. PubMed ID: 33158630
    [Abstract] [Full Text] [Related]

  • 32. Pediatric Gliosarcoma With and Without Neurofibromatosis Type 1: A Whole-exome Comparison of 2 Patients.
    Graham RT, Bell EH, Webb A, Zhao Y, Timmers C, Fleming JL, Sells BE, Robison NJ, Palmer JD, Finlay JL, Chakravarti A.
    J Pediatr Hematol Oncol; 2021 Nov 01; 43(8):e1201-e1204. PubMed ID: 33235140
    [Abstract] [Full Text] [Related]

  • 33. Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients.
    Sana J, Radova L, Lakomy R, Kren L, Fadrus P, Smrcka M, Besse A, Nekvindova J, Hermanova M, Jancalek R, Svoboda M, Hajduch M, Slampa P, Vyzula R, Slaby O.
    Carcinogenesis; 2014 Dec 01; 35(12):2756-62. PubMed ID: 25322872
    [Abstract] [Full Text] [Related]

  • 34. Progressive adult primary glioblastoma in the medulla oblongata with an unmethylated MGMT promoter and without an IDH mutation.
    Yoshikawa A, Nakada M, Watanabe T, Hayashi Y, Sabit H, Kato Y, Suzuki S, Ooi A, Sato H, Hamada J.
    Brain Tumor Pathol; 2013 Jul 01; 30(3):175-9. PubMed ID: 23053494
    [Abstract] [Full Text] [Related]

  • 35. Lipidized glioblastoma: pathological and molecular characteristics.
    Singh AD, Iftinca M, Easaw JC.
    Neuropathology; 2013 Feb 01; 33(1):87-92. PubMed ID: 22640269
    [Abstract] [Full Text] [Related]

  • 36. Increased xCT expression correlates with tumor invasion and outcome in patients with glioblastomas.
    Takeuchi S, Wada K, Toyooka T, Shinomiya N, Shimazaki H, Nakanishi K, Nagatani K, Otani N, Osada H, Uozumi Y, Matsuo H, Nawashiro H.
    Neurosurgery; 2013 Jan 01; 72(1):33-41; discussion 41. PubMed ID: 23096413
    [Abstract] [Full Text] [Related]

  • 37. Clinical correlates of subventricular zone-contacting glioblastomas: a meta-analysis.
    Mistry AM.
    J Neurosurg Sci; 2019 Oct 01; 63(5):581-587. PubMed ID: 29205011
    [Abstract] [Full Text] [Related]

  • 38. Clinical management and survival outcomes of gliosarcomas in the era of multimodality therapy.
    Damodaran O, van Heerden J, Nowak AK, Bynevelt M, McDonald K, Marsh J, Lee G.
    J Clin Neurosci; 2014 Mar 01; 21(3):478-81. PubMed ID: 24332268
    [Abstract] [Full Text] [Related]

  • 39. Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification.
    Ening G, Osterheld F, Capper D, Schmieder K, Brenke C.
    J Cancer Res Clin Oncol; 2015 Jun 01; 141(6):1131-7. PubMed ID: 25577223
    [Abstract] [Full Text] [Related]

  • 40. One decade of glioblastoma multiforme surgery in 342 elderly patients: what have we learned?
    Heiland DH, Haaker G, Watzlawick R, Delev D, Masalha W, Franco P, Machein M, Staszewski O, Oelhke O, Nicolay NH, Schnell O.
    J Neurooncol; 2018 Nov 01; 140(2):385-391. PubMed ID: 30076585
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.